On top of their benefits as obesity meds, research also shows that they offer other health benefits, like improving heart and brain health and reducing addictive behaviors
Akhavan, O., Ghaderi, E., Shirazian, S
Clinical efficacy and body composition changes with sodium glucose cotransporter 2 inhibitor/glucagon-like peptide-1 agonist combination therapy in patients with type 2 diabetes mellitus-associated nonalcoholic fatty liver disease
UCWM (reference category) as the independent variable adjusted for headache frequency at baseline and in a second step also for weight loss to evaluate potential independent treatment effects of GLP-1-RAs
Understanding how your skin responds can help you distinguish between temporary adjustment and irritation, allowing you to manage your routine more effectively
Fill out our 5-minute questionnaire to get started